EP3773147A1 - Method and device for examining the neurovascular coupling at the eye of a patient - Google Patents
Method and device for examining the neurovascular coupling at the eye of a patientInfo
- Publication number
- EP3773147A1 EP3773147A1 EP19717114.3A EP19717114A EP3773147A1 EP 3773147 A1 EP3773147 A1 EP 3773147A1 EP 19717114 A EP19717114 A EP 19717114A EP 3773147 A1 EP3773147 A1 EP 3773147A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- fundus
- eye
- capillary
- images
- signals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1225—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation
- A61B3/1233—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation for measuring blood flow, e.g. at the retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/0008—Apparatus for testing the eyes; Instruments for examining the eyes provided with illuminating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
- A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography
Definitions
- the field of application of the invention relates to the entire vascular medicine, z.
- ophthalmology neurology, cardiology, nephrology, diabetology, hypertensiology.
- microvascular vascular changes are often systemic, i. H. occur in the vessels, in particular the vessels of the microcirculation of all organs of the human and animal body, similar and depending on the organ to different manifestations of cardiovascular diseases, such as atherosclerosis, atherosclerosis, heart failure, renal insufficiency, eye diseases such. As retinopathy and glaucoma, cerebrovascular diseases such. As vascular dementia, and ultimately cardiovascular events, such as heart attack and stroke, can trigger or are predictors.
- the eye as a unique optical window for microcirculation allows the retinal vessels to be examined as a mirror image of the vessels in inaccessible areas of the other organs of the body.
- the field of application of the invention is to investigate vascular endothelial function in human vessels and neurovascular coupling.
- ophthalmology mainly uses imaging techniques and devices for clinical issues that investigate structural, morphological changes in the eye, especially in the retina. These include conventional fundus cameras, OCT, laser scanners, adaptive optics systems, and other vascular investigations using static vessel analysis, such as: B. with the VesselMap Imedos, begin to enter the clinical routine for microvascular risk stratification and therapy control.
- Dynamic vessel analysis allows the study of various autoregulation mechanisms based on continuous measurements of vessel diameter over time and along the location of the so-called large arteries and veins of the microcirculation.
- the retinal vessels are stimulated or provoked during vascular recording and accordingly respond with a constriction or dilatation that describes the vascular response of the respective retinal autoregulatory mechanisms addressed by the type of stimulation or provocation, and their operability.
- One of the autoregulatory mechanisms is the flow-induced autoregulation.
- the state-of-the-art dynamic vessel analysis system is the Dynamic Vessel Analyzer (DVA) from Imedos (Garhofer, G., Bek, T., Böhm, AG, Gherghel, D., Grunwald, J., Jeppesen, P. , Kergoat, Fl., Kotliar, K., Lanzl, I., Lovasik, JV, Nagel, E., Vilser, W., Orgul, S., Schmetterer, L.: "The retinal vessel analyzer in ocular blood flow research. "Acta Ophthalmologica 2010: 88: pp. 717-722).
- DVA Dynamic Vessel Analyzer
- the standard provocation used in the DVA is Flickerlicht, which works in a frequency range of 12.5 Hz and interrupts the green measuring light with an optical shutter flickering for 20 s. This procedure is repeated three times and the vascular responses are then superimposed for averaging and evaluated for maximum dilation and subsequent constriction.
- the parameters of the evaluation are interpreted as biomarkers for the functional diagnosis of the microvascular endothelial function.
- the parameters of the vascular response are also mistaken as parameters of the neurovascular Coupling designates and interprets.
- the neurovascular coupling represents the initial stimulus and thus influences the vascular response
- the vascular response of the large vessels describes the function of the endothelial function.
- WO 2005/094668 A1 describes a device for the photometric measurement of the vessel diameter of smaller vessels.
- the disclosed technical solution allows the measurement of vessel diameters in the arterioles and venules, provided that the vessels in the fundus image are selectable as vessels. For this purpose, two different spectral ranges and a color camera are used. This considerably increases the light load of the retina.
- Another significant disadvantage of the disclosed solutions is also in the rigid lighting side arrangement of a light modulator in the common illumination side beam path, which also can only make the temporal modulation flexible and significantly limits the scope and adaptability, ultimately has the same disadvantages of DVAs, except for Advantage, even on small retinal vessels, but which are significantly larger than capillaries, to be able to measure.
- Two spectral ranges in the red and green spectral range of the white illumination light are selected via a dual band pass filter in the illumination beam path of a conventional retinal camera and assigned to the red and green color channels of a 3-chip CCD color camera in such a way that the two selected illumination-side spectral ranges of the measurement light are separated from each other the two associated red and green color channels of the CCD camera are received.
- quotients are formed and reassigned to the fundus location. The quotient image thus generated is then evaluated for capillary perfusion on the optic nerve head.
- this method does not allow perfusion of the optic nerve head when perfusion is understood as meaning the capillary blood flow, it does provide a measure of the blood volume and thus of the capillary vessel diameter and the capillarization of the considered tissue volumes.
- the disadvantage of this method is that it can not, as described in the aforementioned work, provide functional information about the regulation of capillary "perfusion".
- a first major disadvantage of the prior art is the lack of opportunities to study neurovascular coupling in the retina. Methods for the investigation of neurovascular coupling in the brain are purely experimental, invasive, very expensive and not suitable for clinical use. Neurovascular coupling plays a key role in retinal and cerebral blood flow as well as in various diseases.
- a further disadvantage of the prior art is that the results of studies on vascular endothelial function are very strong and that the connection between endothelial dysfunction and cardiovascular risk factors, events and diseases is unclear, with clinical use for individual endothelial function evaluation and diagnosis of endothelial dysfunction Endothelial dysfunction is flawed and unsettled.
- the object is achieved for a method for the examination of the neurovascular coupling on the eye of a patient with a first method in which an image sequence of images of the fundus of the eye is created and recorded while the fundus is stimulated with a flicker light, wherein from the images of the image sequence for at least one capillary vessel region of the fundus Signals are derived, the capillary vascular responses of the capillary capillary of the capillary area on the stimulation with the flicker light and their maximum absolute or percentage change is determined and used as an evaluation criterion for the neurovascular coupling.
- signals are also derived from the images of the image sequence for at least one vessel section of arterial or venous vessels of the fundus, which represent arterial or venous vascular responses to the stimulation and whose maximum absolute or percentage change is determined, which represents an evaluation criterion for the endothelial function.
- the signals describing the vascular responses may represent intensities, vascular diameters, blood volume values, quotient signals from various spectral ranges, blood flow values, vascular densities or blood velocity values of the capillary or larger arterial or venous vessels.
- the recording of the sequence of images of the fundus of the eye is advantageously carried out via a baseline phase, a stimulation phase in which the fundus is stimulated by the flicker light, and a post-phase (NP).
- the method integrates the study of endothelial function in the large retinal vessels using the vascular response describing the neurovascular coupling as a reference for evaluating the vascular response describing endothelial function. It does not matter how the reference is implemented. An example is the formation of a quotient of the percent maximal dilatation of the large vessels and the maximum percentage change of the vascular response of the neurovascular coupling.
- the information about the strength of the neurovascular coupling is sufficient to evaluate the investigated vascular endothelial function.
- the influence of the neuronal coupling on the study of the vascular endothelial function can be eliminated, thus avoiding errors in the evaluation of the endothelial function and significantly improving the diagnostic safety.
- the object of a method for the examination of the neurovascular coupling on the eye of a patient is also solved by a second method, in which an image-forming method is used to sequence images of the fundus of the eye over a baseline phase, a stimulation phase in which the fundus a flare light is stimulated, and a post-phase (NP) is recorded, wherein the fundus is illuminated with measuring light of two different spectral ranges, derived from intensity values of the images of the image sequence for at least one capillary vascular area of the fund quotient signals that a capillary vascular response of the vessels of at least represent a capillary vascular area on the stimulation, and from the quotient signals and / or a quotient signal averaged from the quotient signals, an absolute or percentage maximum change is determined and used as an evaluation criterion for the neurovascular coupling.
- an image-forming method is used to sequence images of the fundus of the eye over a baseline phase, a stimulation phase in which the fundus a flare light is stimulated,
- diameter signals are derived from the images of the image sequence for at least one vessel section of arterial or venous vessels of the fundus in the second method, which represent an arterial or venous vascular response of the at least one vessel section to the stimulation, and an average diameter signal is formed from the diameter signals Absolute or percentage maximum change is determined, which is an evaluation criterion for endothelial function.
- the images can be assigned to two color channels, determined by one of the spectral ranges, and a quotient signal derived from the intensity values of the two color channels can be formed as the signal.
- the imaging method is based on optical coherence tomography and the images are OCT images.
- the flicker light preferably has a spectral range that differs from the measurement light, with which the measurement light and the flicker light can be adjusted independently of one another.
- the maximum change in the quotient signal and / or the diameter signal is color-coded in a mapping image to which at least one capillary vessel region and / or the at least one vessel section are assigned.
- a device for the examination of the neurovascular coupling on the eye of a patient comprises: an imaging system for generating an image sequence of images of the fundus of the eye, the image intensities of the fundus-characterizing structures, the capillary density , which represent blood velocity, the blood flow or the blood volume of the vessels, with a lighting unit for generating flicker light, with which at least a portion of the fundus is stimulated, a data and image processing unit, designed for the selection of capillary vascular areas and vascular sections of arterial and venous vessels the pictures of the sequence, a unit for deriving signals associated with the selected capillary vascular areas and the selected vascular sections; a signal analysis unit and a result and presentation unit.
- a second device which comprises: an imaging system for generating an image sequence of images of the fundus of the eye, with a lighting unit designed to generate a measuring light, with at least two spectral ranges for illumination, as well as for generating a flicker light for stimulating the fundus, a data and image processing unit, designed for the selection of capillary vascular areas and vascular sections of arterial and venous vessels in the images of the image sequence, a unit for the derivation of quotient signals, assigned to the selected capillary vascular regions, a unit for deriving diameter signals associated with the selected vascular sections, a signal analysis unit and a result and presentation unit, the illumination unit being characterized by a structured arrangement is formed by adaptively controllable LEDs as a lighting structure with at least three different spectral ranges which can be changed in terms of geometry and dimension, with which selected capillary vessel areas and / or selected vessel sections can be adaptively illuminated
- the LEDs of two spectral regions generate the measuring light and, independently of this, the LEDs of the third spectral range generate the flicker light.
- the spectral ranges of the LEDs that generate the measurement light are preferably green and red, and the spectral range of the LEDs that produce the flicker light is blue.
- the digital image sensor is advantageously a color image sensor with at least two color channels.
- the digital image sensor is a monochromatic image sensor, wherein the spectral ranges of the measuring light within and the spectral range of the flicker light are outside the spectral sensitivity of the digital image sensor.
- FIG. 2 shows a block diagram of a device suitable for carrying out the method
- FIG. 3 shows an image of the fundus, in which exemplary capillary vascular areas, one of which is indicated on the optic nerve head, measuring locations and vessel sections, and
- FIG. 4 shows a block diagram of a further device suitable for carrying out the method.
- a method for the examination of the neurovascular coupling on the eye A an image sequence of images of the fundus of the eye A is preferred over a baseline phase BP, a stimulation phase SP, in which the fundus is stimulated with a flicker light, and a postphase NP recorded, see Fig- 1.
- a signal is derived for at least one capillary vessel region KGB, which represents a capillary vascular response (signal of a measured variable) of the capillary vessels to the stimulation of the retina and whose maximum change during the stimulation phase SP represents an evaluation criterion (biomarker) for the NPC.
- a capillary vascular response may be the changes in capillary blood flow or capillary blood velocity, capillary vessel diameter, or capillary blood volume in the retina or on the optic nerve head during the stimulation phase SP.
- the sequence of images z. B. by optical coherence tomography OCT, via a scan method or by other optical imaging methods are generated.
- the change of the capillary blood volume or the vessel diameter of the capillary vessels which is a change in the retinal capillary vessel areas KGB or the papillary capillary vessel areas KGB (on the papilla) reflected portion of the measurement light result, detected by a normalized intensity signal (quotient signal Q (t, x, y)), which is used as a capillary vascular response to study the NVK.
- a normalized intensity signal quotient signal Q (t, x, y)
- the method integrates the examination of the endothelial function in the large arterial and / or venous retinal vessels.
- Step 0
- the examiner is given an examination program menu for various examinations with different medical procedures Issues offered.
- the parameters of the measuring light and the parameters of the flicker light are set by selecting the examination parameters.
- the examiner can choose between setting 0-1: freely selected parameters (free parameter selection),
- 0-3 select from repeat parameters (repeat mode) as described in the following steps.
- Step 0-1 Free parameter selection
- the examiner is preferably offered the following parameters for automatic presetting and after selection the parameter set is stored under a name to be given by the examiner as a new program for comparison and repeat examinations.
- Step 0-1 -1 Setting the measuring light (measuring light parameter)
- spectral ranges of the measuring light preferably green and red, when a normalized intensity signal (quotient signal Q (t, x, y)) is to be derived from the image sequences, and defining a spectral range, eg. B. green, when a non-normalized intensity signal is to be derived from the image sequences
- the measuring light and the flicker light have the same spectral range (eg green), z. B. at a frame rate of 25 Hz, the measuring light during the stimulation phase SP at every second image with a predetermined Modulation depth turned off to realize a flicker stimulation frequency of 12.5 Hz.
- a different spectral range is determined for the measuring light and the flicker light.
- blue is also preferred as additional measuring light in conjunction with red.
- Step 0-1 -2 Setting the Flicker Light (Flicker Light Parameter)
- the specified spectral range of the flicker light is only modulated according to the other flicker parameters.
- flicker light changes only the spectral range with the flicker frequency, which means a mutual switching of different color LEDs.
- the adjustment of the spectral ranges of the colored LEDs is made depending on the flicker type, eg.
- the flicker light change is determined by a blue LED with a green LED.
- the examiner can set the stimulation shape for each half period of the flicker light with the following parameters:
- the flicker frequency can basically be set independently of the frame rate.
- Step 0-1 -3 Setting the examination phases (phase parameters)
- the length of the examination phases baseline phase BP, stimulation phase SP and postphase NP are set.
- Step 0-1 -4
- Step 0-2 Comparison mode (assures same examination conditions for different eyes A for the same medical question)
- the desired examination program for the medical question is retrieved from the examination menu and the associated parameter set for the selected examination program is loaded.
- the LEDs of a device for carrying out the method are correspondingly driven, whereby the measuring light and the flicker light are variably and adaptively adapted to the selected examination program.
- Step 0-3 Repeat mode (secures equal examination conditions in subsequent sessions for the same eye A) with reference measurement locations
- the previously examined eye A is searched out and the parameter sets of the examination carried out by the last examination are preset.
- a movement correction ensures the exact match of the areas of the fundus between the sessions recorded in the images of the image sequences.
- Step 1
- the head of the patient is fixed over a head and chin rest against an imaging system 1.
- the imaging system 1 is adjusted to the eye A to be examined in such a way that it provides a low-scattering and reflection-free image of the fundus.
- the imaging system 1 starts taking a sequence of images.
- images of two color channels are generated synchronously when the fundus is illuminated with measuring light of two spectral ranges, for example with green and with red measuring light. They are understood below as images to which two color channels are assigned.
- a monochromatic image sensor may be used as the digital image sensor 2.
- images are also generated, which are assigned to a pseudo-green color channel and a pseudo-red color channel and are subsequently understood in pairs as images to which two color channels are assigned.
- the image change and the spectral change of the measuring light are carried out at such a high frequency that a possible stimulation effect is negligible.
- the flicker light remains off during the baseline phase BP.
- Step 3 The images of the image sequences are motion-corrected with respect to the eye movements.
- Capillary vascular areas KGB are selected in the images of the fundus, and quotient signals Q (t, x, y) are preferably formed beginning with the acquisition of the images from the intensity values of the red and green color channels of the images and assigned to one of the selected capillary vascular areas KGB stored.
- the values of the parameters of the quotient signals Q (t, x, y) over the duration of the baseline phase BP provide baseline values from which a mean baseline value is determined.
- diameter signals D (t, x, y) are derived at the same time from the intensity values of the green color channels of the images of the image sequence.
- the vessel diameter along the selected vessel sections GA segment by segment which are each assigned to a measurement site M (x, y), determined, stored with location correction and assigned to a synchronization signal or the individual images of the image sequence. From the determined diameters, diameter signals D (t, x, y) are formed for each vessel segment.
- the values of the parameters of the diameter signals D (t, x, y) over the duration of the baseline phase BP provide baseline values from which a mean baseline value is determined.
- the baseline phase BP is automatically followed by the stimulation phase SP with the stimulation time and the parameter set transferred for the flicker light stimulation.
- Said vessel signals that is, the quotient signals Q (t, x, y) and the diameter signals D (t, x, y) are further derived from the image sequences during the stimulation phase SP.
- the measuring light of both spectral regions is switched off synchronously to the image sequence in the flicker phases of the blue flicker light, while in the dark phase of the flicker light the measuring light is switched on and the images and consequently the vessel signals are generated.
- the Recording of the images and the derivation of the vessel signals also take place during the bright phase of the flicker light.
- the flicker-related changes of the quotient signals Q (t, x, y) and the diameter signals D (t, x, y) are evaluated for their scattering and dilation. It is separated for the individual quotient signals Q (t, x, y) or for an averaged quotient signal Q (t) or for the individual diameter signals D (t, x, y) or respectively for the arterial vessel sections GA and the venous vessel sections GA an average diameter signal D (t) is formed. From the averaged quotient signal Q (t) becomes Q ma x and from the averaged diameter signals D (t) D max is determined as maximum change of the signal.
- the post-phase NP of the examination begins, the flicker light is switched off and the continuous measurements are continued until the post-phase NP is ended.
- the stimulation phase SP and the post-phase NP can be repeated several times, preferably three times alternately, to average the signals.
- the signals Q (t, x, y) and D (t, x, y) are averaged over the selected KGB and GA, recorded and output as a measurement protocol with the derived maximum values of the signal changes.
- Such a device contains, as shown in a block diagram in Fig. 2, an imaging system 1, here a modified retinal camera, with a digital image sensor 2 and a lighting unit 3 for generating a measuring light and a Flickerlichtes, a control unit 4, a data and Image processing unit 5, a unit for deriving diameter signals 6, a signal analysis unit 7, a result and presentation unit 8, an input and output unit 9 and a unit for deriving quotient signals 10.
- the illumination unit 3 is arranged in an illumination beam path of the retinal camera in a plane conjugated to the eye pupil, that is to say it is imaged into the eye pupil of the eye A.
- the fundus of the eye A is imaged sharply on a receiving surface of the digital image sensor 2.
- the lighting unit 3 is a preferably adaptive, structured, annular arrangement of small light sources, for.
- LEDs with three different spectral properties preferably in the blue, green and red spectral range.
- the LEDs are controlled via the control unit 4 in such a way that the LED light intensity of the differently colored LEDs is modeled separately and independently of one another.
- the modulation of the LED light should allow both the adjustment of the radiation intensity of light as measuring light, as well as the setting of flicker light by switching between high and low radiation intensity, with adjustable parameters of the frequency, the degree of modulation and the alternating light form (eg wavy to step-shaped, symmetrical or asymmetric change between light and dark phase).
- the luminous structure formed by the active (luminous) LEDs in their geometry and dimension, z.
- an active light ring formed adaptively adaptable.
- the annular LED array in the lighting side aperture can be used to reduce stray light or reflection light (especially on the vessels). This also makes it possible to very quickly switch the dynamic vessel analysis into the mode of nonmydriatic static vessel analysis and vice versa.
- this adaptivity can be used to focus the fundus on the principle of Scheiner 's diaphragms. It is also possible to use a structural change that is rotating during the examination to acquire image sequences with different illumination geometries.
- the digital image sensor 2 may be a color sensor that synchronously generates images that are green and red when illuminated with green and red measurement light red color channel can be assigned.
- the two synchronous images are each understood as an image to which two color channels are assigned.
- a monochromatic image sensor is used as the digital image sensor 2, which is preferably sensitive only to the two spectral ranges of the measurement light, but not to the spectral range of the flicker light.
- the digital image sensor 2 is preferably sensitive only to the two spectral ranges of the measurement light, but not to the spectral range of the flicker light.
- the images are alternately assigned to a pseudo-green or a pseudo-red color channel.
- Two consecutively taken pictures are understood as one picture to which two color channels are assigned.
- the frame rate is set so high that the color change of the measurement light does not lead to a stimulation effect.
- the two pseudocolor channels of the monochromatic image sensor have a higher sensitivity and the monochromatic image sensor a higher resolution than the color image sensor.
- the adaptive control unit 4 is connected to the data and image processing unit 5, which in turn is connected to the digital image sensor 2. It controls the individual LEDs of the illumination unit 3 separately from each other and with different radiation intensity, but at least when they emit the measurement light, synchronized to the image sequence.
- the frequency of the flicker light (change between light and dark) is controlled by a synchronization signal which is generated by the digital image sensor 2 and transferred to the control unit 4.
- the synchronization signal With the synchronization signal, the signals formed during the method steps are synchronized with the image sequence recorded by the digital image sensor 2. It does not matter whether the synchronization signal is given by the digital image sensor 2 or by the data and image processing unit 5, which also controls the recording of the images of the image sequence.
- the color image sensor records images of the fundus at a frame rate of preferably 25 Hz, which yields preferably 12.5 Hz as the flicker frequency.
- any other frame rate can be used synchronized to a flicker frequency for the device and the method.
- the frame rate and the flicker frequency also need not be synchronized with each other if there is no overlap of the spectral ranges of the measuring light and the flicker light.
- the data and image processing unit 5 connected to the digital image sensor 2 receives the image sequence.
- the examiner selects via the data and image processing unit 5 and the input and output unit 9 in the images, see FIG. 3, the capillary vessel areas KGB in the retina or the optic nerve head and assigns them each a measuring location M (x, y) ,
- a measuring location M (x, y) can be defined by a pixel or an image area and thus a pixel or a pixel group of the digital image sensor 2.
- the measurement location M (x, y) may be the centroid of the KGB or another selected point in the KGB.
- larger venous and arterial vessel sections GA are selected in the images, which also have measuring locations M (x, y) and thus image points or individual pixels, which preferably represent the center point of the respective vessel segment, or image areas, in this case the vessel segments. or a pixel group on the digital image sensor 2 are assigned.
- the selected KGB are advantageously between the selected vessel sections GA.
- the coordinates of the measurement locations M (x, y) assigned to the KGBs and the green and red intensity values generated by the green and red measurement light at the measurement locations M (x, y) are transferred to the unit for deriving quotient signals 10.
- the coordinates of the vessel segments or the associated measuring locations M (x, y) and the intensity values generated by the green measuring light are forwarded to the unit for deriving diameter signals 6.
- the unit for deriving quotient signals 10 forms on-line from image to image and as a function of time quotients of the green and red intensity values of Images for all measuring locations M (x, y) of the KGBs and forwards these values as quotient signals Q (t, x, y) to the signal analysis unit 7.
- the unit for deriving diameter signals 6 only has to be present if the device is also to be used advantageously to examine the vascular endothelial function in addition to the investigation of the neurovascular coupling.
- the unit for deriving diameter signals 6 determines the diameter on-line via image processing of the green color signals segment by segment and image by image, forms time and location-dependent diameter signals D (t, x, y) and forwards them to the signal analysis unit 7.
- the endothelium-descriptive parameters of the vessels such as the dilation maximum in the stimulation phase SP is calculated and output via the result and presentation unit 8 and the input and output unit 9.
- the result and presentation unit 8 also serves to create mapping images.
- the signal analysis unit 7 determines as parameters of the signals the maximum change in the vessel diameter, equal to the maximum dilation D max , from the diameter signals D (t, x, y) for the vessel segments or vessel sections GA or from the averaged diameter signals D (t) and the maximum change Q max from the quotient signals Q (t, x, y) for the capillary vessel areas KGB.
- the maximum dilation D max describes the endothelial function and the maximum change Qmax describes the NKV.
- the parameters are transferred to the result and presentation unit 8, entered in a result image (mapping image) in the correct position (motion-corrected) and output as an examination result.
- the test results on NVK and on the endothelial function can be evaluated separately, but advantageously medically related.
- the investigation of the NVK on the basis of quotient signals Q (t, x, y) has the advantage that the blood volume of the KGBs is detected on the basis of spectrally normalized intensity values. Since these intensity values are independent of illumination, a different illumination of the measuring locations M (x, y) as a result of eye movements has at most negligible influence on the parameters describing the NVK.
- a further exemplary embodiment of a method and a device according to the invention results if, instead of a modified fundus camera as described above, a laser scanner is used as the imaging system 1, with laser beams whose wavelengths are matched to the spectral ranges of the measurement light and the flicker light already described above are.
- the method and the device are carried out analogously to the above description.
- Imaging systems 1 based on optical coherence tomography Signals are derived from the images, here called OCT images, which describe both the local vessel diameter of larger vessels and / or the local blood volume or the local perfusion of the capillaries. Such signals may be derived from local blood flow, local blood or cell velocity, or capillary density
- An imaging system 1 based on optical coherence tomography is, for example, an angiograph (OCT-A), in whose OCT images the signals are due to the moving blood cell density or those with blood cells perfused capillaries are shown.
- the device for examining the neurovascular coupling on the eye A of a patient may contain any imaging system 1 for generating an image sequence of images of the fundus of the eye A.
- the imaging system 1 merely has to be designed to produce images in which imagewise intensities of the structures characterizing the fundus, the capillary density, the blood velocity, the blood flow or the blood volume of the vessels are shown.
- a lighting unit 3 for generating flicker light is present, with which at least a section of the fundus can be stimulated.
- the device has a data and image processing unit 5, designed for the selection of capillary vascular areas KGB and vascular sections GA arterial and venous vessels from the images of the image sequence, a unit for deriving signals 1 1, associated with the selected capillary vascular areas KGB and the selected Vessel sections GA, a signal analysis unit 7 and a result and presentation unit 8 have.
- a data and image processing unit 5 designed for the selection of capillary vascular areas KGB and vascular sections GA arterial and venous vessels from the images of the image sequence
- a unit for deriving signals 1 1, associated with the selected capillary vascular areas KGB and the selected Vessel sections GA a signal analysis unit 7 and a result and presentation unit 8 have.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Eye Examination Apparatus (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102018107623.1A DE102018107623A1 (en) | 2018-03-29 | 2018-03-29 | Method and device for investigating neurovascular coupling in the eye of a patient |
PCT/DE2019/100295 WO2019185096A1 (en) | 2018-03-29 | 2019-03-29 | Method and device for examining the neurovascular coupling at the eye of a patient |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3773147A1 true EP3773147A1 (en) | 2021-02-17 |
Family
ID=66102843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19717114.3A Pending EP3773147A1 (en) | 2018-03-29 | 2019-03-29 | Method and device for examining the neurovascular coupling at the eye of a patient |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210113080A1 (en) |
EP (1) | EP3773147A1 (en) |
JP (1) | JP7373502B2 (en) |
KR (1) | KR20200138332A (en) |
CN (1) | CN112004456A (en) |
DE (2) | DE102018107623A1 (en) |
WO (1) | WO2019185096A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118076300A (en) * | 2021-10-12 | 2024-05-24 | 国家医疗保健研究所 | Method and device for measuring neurovascular coupling |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001022741A2 (en) * | 1999-09-23 | 2001-03-29 | Nadeau Richard G | Medical applications of orthogonal polarization spectral imaging |
JP4171652B2 (en) * | 2001-01-03 | 2008-10-22 | ヴァルトハルト ヴィルサー | Apparatus and methods for imaging, stimulation, measurement and treatment, especially for the eye |
JP2003190096A (en) * | 2001-12-26 | 2003-07-08 | Canon Inc | Ophthalmic equipment |
DE10357734B4 (en) * | 2003-12-05 | 2009-10-01 | Imedos Gmbh | Universal ophthalmological examination device and ophthalmological examination method |
JPWO2005084526A1 (en) * | 2004-02-20 | 2007-11-29 | 独立行政法人理化学研究所 | Optical measurement method and apparatus for retinal function |
DE102004008675B4 (en) * | 2004-02-20 | 2009-05-07 | Imedos Gmbh | Imaging method for recording medically relevant differences of structures and properties of an examination object and device suitable for this purpose |
DE102004017130B4 (en) * | 2004-04-02 | 2006-01-19 | Imedos Gmbh | Method for measuring the vessel diameter of optically accessible blood vessels |
WO2006121984A2 (en) * | 2005-05-06 | 2006-11-16 | Yeda Research And Development Co., Ltd. | Erythrocyte movement imaging and analysis |
DE102005034332A1 (en) * | 2005-07-22 | 2007-01-25 | Carl Zeiss Meditec Ag | Apparatus and method for observation, documentation and / or diagnosis of the ocular fundus |
JP2010172614A (en) * | 2009-01-30 | 2010-08-12 | Topcon Corp | Function imaging ophthalmic apparatus |
US10368734B2 (en) * | 2015-02-19 | 2019-08-06 | Carl Zeiss Meditec, Inc. | Methods and systems for combined morphological and angiographic analyses of retinal features |
DE102018107625A1 (en) * | 2018-03-29 | 2019-10-02 | Imedos Systems GmbH | Apparatus and method for examining retinal vascular endothelial function |
-
2018
- 2018-03-29 DE DE102018107623.1A patent/DE102018107623A1/en not_active Withdrawn
-
2019
- 2019-03-29 CN CN201980023842.XA patent/CN112004456A/en active Pending
- 2019-03-29 JP JP2020552761A patent/JP7373502B2/en active Active
- 2019-03-29 DE DE112019001645.8T patent/DE112019001645A5/en not_active Withdrawn
- 2019-03-29 EP EP19717114.3A patent/EP3773147A1/en active Pending
- 2019-03-29 WO PCT/DE2019/100295 patent/WO2019185096A1/en unknown
- 2019-03-29 US US17/042,836 patent/US20210113080A1/en active Pending
- 2019-03-29 KR KR1020207031087A patent/KR20200138332A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20210113080A1 (en) | 2021-04-22 |
DE102018107623A1 (en) | 2019-10-02 |
JP7373502B2 (en) | 2023-11-02 |
WO2019185096A1 (en) | 2019-10-03 |
KR20200138332A (en) | 2020-12-09 |
CN112004456A (en) | 2020-11-27 |
DE112019001645A5 (en) | 2020-12-17 |
JP2021519177A (en) | 2021-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1906811B1 (en) | Device and method for monitoring, documenting and/or diagnosing the fundus | |
EP2386244B1 (en) | Ophthalmoscope | |
DE102004062226B4 (en) | Device for viewing a fundus | |
EP2445387B1 (en) | Fixation control device and method for controlling the fixation of an eye | |
Elsner et al. | Reflectometry with a scanning laser ophthalmoscope | |
DE112013006234B4 (en) | Ophthalmic device | |
DE10290005B4 (en) | Apparatus and method for imaging, stimulation, measurement and therapy, especially on the eye | |
EP1716804A1 (en) | Retina function optical measuring method and instrument | |
DE112017000663T5 (en) | Ophthalmological device and ophthalmological examination system | |
EP3773143B1 (en) | Device and method for examining the retinal vascular endothelial function | |
DE102015200794A1 (en) | Ophthalmological device | |
WO2005079658A2 (en) | Device and method for recording and representing images of a test object | |
DE112019002024T5 (en) | Image processing method, program and image processing device | |
DE112016004722T5 (en) | Ophthalmic imaging device and ophthalmic information processing device | |
DE112019002013T5 (en) | Image processing method, program and image processing device | |
EP2983576B1 (en) | Method for photographically observing and/or documenting the fundus of an eye, and fundus camera | |
DE10357734B4 (en) | Universal ophthalmological examination device and ophthalmological examination method | |
DE102007047460A1 (en) | Apparatus and method for examining the ocular fundus, in particular the photoreceptors | |
EP3773147A1 (en) | Method and device for examining the neurovascular coupling at the eye of a patient | |
DE4422071A1 (en) | Device for measurement of the retinal blood flow rate | |
EP0390896B1 (en) | Device for examining the field of vision | |
WO2014125063A1 (en) | Arrangement and method for automatically lighting fundus images | |
DE102005008106B4 (en) | Method and device for determining a circulatory disorder | |
DE102022112499A1 (en) | OPTICAL SYSTEM AND DEVICE AND SYSTEM FOR PICKING THE FUND OF THE EYE | |
WO2023144189A1 (en) | Optical assembly for detecting radiation of a retina projector reflected by the eye, and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201029 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230307 |